These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8825219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia.
    Estellés A, Gilabert J, Aznar J, Loskutoff DJ, Schleef RR.
    Blood; 1989 Sep; 74(4):1332-8. PubMed ID: 2504307
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy.
    Astedt B, Lindoff C, Lecander I.
    Semin Thromb Hemost; 1998 Sep; 24(5):431-5. PubMed ID: 9834009
    [Abstract] [Full Text] [Related]

  • 8. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia.
    Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J.
    Br J Obstet Gynaecol; 1994 Jun; 101(6):488-92. PubMed ID: 8018635
    [Abstract] [Full Text] [Related]

  • 9. Fibrinolysis parameters in Sudanese women with severe preeclampsia.
    Elzein HO, Muddathir AR, Rida M, Rayis DA, Elhassan EM, Adam I.
    Hypertens Pregnancy; 2016 Nov; 35(4):559-564. PubMed ID: 27598010
    [Abstract] [Full Text] [Related]

  • 10. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation.
    Estellés A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, Espña F, Loskutoff DJ, Schleef RR.
    Blood; 1994 Jul 01; 84(1):143-50. PubMed ID: 8018914
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole.
    Reith A, Booth NA, Moore NR, Cruickshank DJ, Bennett B.
    Br J Obstet Gynaecol; 1993 Apr 01; 100(4):370-4. PubMed ID: 8494839
    [Abstract] [Full Text] [Related]

  • 12. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation.
    Schjetlein R, Haugen G, Wisløff F.
    Acta Obstet Gynecol Scand; 1997 Jul 01; 76(6):541-6. PubMed ID: 9246959
    [Abstract] [Full Text] [Related]

  • 13. Increased immunohistochemical expression of thrombomodulin at placental perivascular myofibroblast in severe preeclampsia (PE).
    Bosco C, Parra M, Barja P, Rodrigo R, Fernández V, Suarez M, Muñoz H.
    Histol Histopathol; 2005 Oct 01; 20(4):1045-55. PubMed ID: 16136486
    [Abstract] [Full Text] [Related]

  • 14. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia.
    Estellés A, Gilabert J, Grancha S, Yamamoto K, Thinnes T, España F, Aznar J, Loskutoff DJ.
    Thromb Haemost; 1998 Mar 01; 79(3):500-8. PubMed ID: 9580327
    [Abstract] [Full Text] [Related]

  • 15. Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease.
    Estellés A, Grancha S, Gilabert J, Thinnes T, Chirivella M, España F, Aznar J, Loskutoff DJ.
    Am J Pathol; 1996 Oct 01; 149(4):1229-39. PubMed ID: 8863672
    [Abstract] [Full Text] [Related]

  • 16. Plasminogen activators and plasminogen activator inhibitors in plasma of premature and term newborns.
    Astedt B, Lindoff C.
    Acta Paediatr; 1997 Jan 01; 86(1):111-3. PubMed ID: 9116413
    [Abstract] [Full Text] [Related]

  • 17. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia.
    Schjetlein R, Abdelnoor M, Haugen G, Husby H, Sandset PM, Wisløff F.
    Acta Obstet Gynecol Scand; 1999 Mar 01; 78(3):191-7. PubMed ID: 10078579
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fibronectin, plasminogen activator inhibitor type 1 (PAI-1) and uterine artery Doppler velocimetry as markers of preeclampsia.
    Bodova KB, Biringer K, Dokus K, Ivankova J, Stasko J, Danko J.
    Dis Markers; 2011 Mar 01; 30(4):191-6. PubMed ID: 21694445
    [Abstract] [Full Text] [Related]

  • 20. Early pregnancy plasminogen activator inhibitor-1 levels in Nigerian women and its relationship with preeclampsia.
    Udenze IC, Arikawe AP, Makwe CC.
    Niger J Clin Pract; 2017 May 01; 20(5):517-522. PubMed ID: 28513507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.